Find Provider Providers Find Locations Locations Care Services Services Patients Patients
Filter by CategoryExpand Menu
Continuing Education for Healthcare Professionals

Feb 11: Pediatric Updated – ADHD

female teenager stares at a smartphone

February 11, 2026, 6:45 – 7:45pm

This presentation will also be recorded and made available for enduring material.

Speaker:

  • James Waxmonsky, MD. Professor of Psychiatry, Department of Psychiatry and Behavioral Health, Penn State College of Medicine

Activity Description:

  • This activity will provide healthcare professionals with information regarding pediatric ADHD screening methods, guidelines for care and treatment, and pharmacological/nonpharmacological/behavioral interventions.

Target Audience:

  • This program is designed for pediatricians, primary/family physicians and advanced practice providers, residents, nurses, students, and others interested in the health and well-being of children.
  • All of these types of healthcare professionals may care for children with ADHD.

Register Now

Continuing Medical Education Designation:

  • The Mount Nittany Medical Center designates this live activity for 1 AMA PRA Category 1 Credit(s)™.
  • This program meets the criteria for 1 of the 12 hours required in patient safety/risk management as defined by the PA State Board of Medicine.

Accreditation:

  • The Mount Nittany Medical Center is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Nursing Contact Hours:

  • This activity has been approved for 1 nursing continuing professional development (NCPD) contact hour.
  • Mount Nittany Medical Center is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Completion Criteria:

In order to receive CME/NCPD contact hours, you must:

  • Attend the entire presentation
  • Complete the evaluation that is provided at the end of the program.

Disclosure:

  • James Waxmonsky, MD has disclosed financial relationships with Collegium Pharmaceuticals (consultant) and Supernus Pharmaceuticals (consultant/research contract). These relationships have been mitigated.
  • None of the other planners, faculty, or others in control of content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
  • This activity received no commercial support or sponsorship.

Questions:

Please contact:

 

Topics